SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000895345-21-000387
Filing Date
2021-03-22
Accepted
2021-03-22 21:36:08
Documents
1
Period of Report
2021-03-18

Document Format Files

Seq Description Document Type Size
1 form4.html 4  
1 form4.xml 4 6206
  Complete submission text file 0000895345-21-000387.txt   8749
Mailing Address C/O NEW MOUNTAIN CAPITAL, L.L.C. 787 SEVENTH AVENUE, 49TH FLOOR NEW YORK NY 10019
Business Address
KLINSKY STEVEN B (Reporting) CIK: 0001018327 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36845 | Film No.: 21762924

Mailing Address 787 7TH AVENUE 49TH FLOOR NEW YORK NY 10019
Business Address 787 7TH AVENUE 49TH FLOOR NEW YORK NY 10019 (212) 720-0300
New Mountain Capital, L.L.C. (Reporting) CIK: 0001407718 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36845 | Film No.: 21762925

Mailing Address 787 SEVENTH AVENUE 49TH FLOOR NEW YORK NY 10019
Business Address 787 SEVENTH AVENUE 49TH FLOOR NEW YORK NY 10019 212-720-0300
New Mountain Investments II, LLC (Reporting) CIK: 0001415950 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-36845 | Film No.: 21762926

Mailing Address 184 LIBERTY CORNER ROAD, SUITE 302 WARREN NJ 07059
Business Address 184 LIBERTY CORNER ROAD, SUITE 302 WARREN NJ 07059 908-574-4770
Bellerophon Therapeutics, Inc. (Issuer) CIK: 0001600132 (see all company filings)

IRS No.: 473116175 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations